West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 446,200 | 601,800 | 853,900 | 898,600 | 796,300 |
| Receivables | 479,400 | 524,000 | 512,000 | 519,100 | 534,400 |
| Inventories | 419,200 | 429,900 | 434,700 | 431,800 | 449,400 |
| Other current assets | 138,200 | 137,200 | 135,800 | 122,800 | 94,100 |
| TOTAL | $1,483,000 | $1,692,900 | $1,936,400 | $1,972,300 | $1,874,200 |
| Non-Current Assets | |||||
| PPE Net | 1,493,700 | 1,448,600 | 1,413,300 | 1,311,600 | 1,261,300 |
| Investments And Advances | 198,200 | 202,500 | 210,000 | 195,400 | 202,800 |
| Intangibles | 120,200 | 121,500 | 123,600 | 122,500 | 124,800 |
| Other Non-Current Assets | 194,300 | 136,800 | 146,200 | 152,900 | 206,500 |
| TOTAL | $2,006,400 | $1,909,400 | $1,893,100 | $1,782,400 | $1,795,400 |
| Total Assets | $3,489,400 | $3,602,300 | $3,829,500 | $3,754,700 | $3,669,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 211,700 | 240,100 | 242,400 | 219,800 | 218,000 |
| Accrued Expenses | 82,900 | 66,500 | 105,900 | 105,500 | 112,100 |
| Other current liabilities | 169,000 | 173,600 | 155,200 | 136,500 | 163,100 |
| TOTAL | $633,700 | $648,400 | $671,800 | $533,500 | $511,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,900 | 72,800 | 72,800 | 152,100 | 205,600 |
| Other Non-Current Liabilities | 176,800 | 169,200 | 172,600 | 166,500 | 169,700 |
| TOTAL | $278,900 | $273,300 | $276,700 | $353,000 | $411,300 |
| Total Liabilities | $912,600 | $921,700 | $948,500 | $886,500 | $922,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,542 | 72,843 | 73,299 | 73,990 | 73,861 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 3,720,900 | 3,624,100 | 3,523,400 | 3,415,900 | 3,254,600 |
| Other shareholders' equity | -216,400 | -192,500 | -143,400 | -223,100 | -183,900 |
| TOTAL | $2,576,800 | $2,680,600 | $2,881,000 | $2,868,200 | $2,746,700 |
| Total Liabilities And Equity | $3,489,400 | $3,602,300 | $3,829,500 | $3,754,700 | $3,669,600 |